Li Q, Zhang B, Cao H, Liu W, Guo F, Shen F, et al. Oxytocin Exerts Antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC. Neuropharmacology. 2020;162:107836 pubmed publisher

Liu Z, Jiang X, Gao L, Liu X, Li J, Huang X, et al. Synergistic Suppression of Glioblastoma Cell Growth by Combined Application of Temozolomide and Dopamine D2 Receptor Antagonists. World Neurosurg. 2019;: pubmed publisher

Janssens G, Lin X, Millán Ariño L, Kavšek A, Sen I, Seinstra R, et al. Transcriptomics-Based Screening Identifies Pharmacological Inhibition of Hsp90 as a Means to Defer Aging. Cell Rep. 2019;27:467-480.e6 pubmed publisher

Randlett O, Haesemeyer M, Forkin G, Shoenhard H, Schier A, Engert F, et al. Distributed Plasticity Drives Visual Habituation Learning in Larval Zebrafish. Curr Biol. 2019;29:1337-1345.e4 pubmed publisher

Caldwell L, Davies N, Cavone L, Mysiak K, Semenova S, Panula P, et al. Regeneration of Dopaminergic Neurons in Adult Zebrafish Depends on Immune System Activation and Differs for Distinct Populations. J Neurosci. 2019;39:4694-4713 pubmed publisher

Lee I, Lee B, Park H, Olausson H, Enck P, Chae Y. A new animal model of placebo analgesia: involvement of the dopaminergic system in reward learning. Sci Rep. 2015;5:17140 pubmed publisher

Pytka K, Partyka A, Jastrzebska Wiesek M, Siwek A, Głuch Lutwin M, Mordyl B, et al. Antidepressant- and Anxiolytic-Like Effects of New Dual 5-HT₁A and 5-HT₇ Antagonists in Animal Models. PLoS ONE. 2015;10:e0142499 pubmed publisher

Mosnaim A, Hudzik T, Wolf M. Behavioral effects of β-phenylethylamine and various monomethylated and monohalogenated analogs in mice are mediated by catecholaminergic mechanisms. Am J Ther. 2015;22:412-22 pubmed publisher

Canfrán Duque A, Pastor O, Reina M, Lerma M, Cruz Jentoft A, Lasunción M, et al. Curcumin Mitigates the Intracellular Lipid Deposit Induced by Antipsychotics In Vitro. PLoS ONE. 2015;10:e0141829 pubmed publisher

Campillo A, Castillo E, Vilke G, Hopper A, Ryan V, Wilson M. First-generation Antipsychotics Are Often Prescribed in the Emergency Department but Are Often Not Administered with Adjunctive Medications. J Emerg Med. 2015;49:901-6 pubmed publisher

Quisenberry A, Baker L. Dopaminergic mediation of the discriminative stimulus functions of modafinil in rats. Psychopharmacology (Berl). 2015;232:4411-9 pubmed publisher

Higashi T, Aiba N, Tanaka T, Yoshizawa K, Ogawa S. Methods for differential and quantitative analyses of brain neurosteroid levels by LC/MS/MS with ESI-enhancing and isotope-coded derivatization. J Pharm Biomed Anal. 2016;117:155-62 pubmed publisher

Neiens P, Höfner G, Wanner K. MS Binding Assays for D1 and D5 Dopamine Receptors. ChemMedChem. 2015;10:1924-31 pubmed publisher

Almeida Santos A, Ferreira R, Duarte I, Aguiar D, Romero T, Moreira F. The antipsychotic aripiprazole induces antinociceptive effects: Possible role of peripheral dopamine D2 and serotonin 5-HT1A receptors. Eur J Pharmacol. 2015;765:300-6 pubmed publisher

Rivera García M, López Rubalcava C, Cruz S. Preclinical characterization of toluene as a non-classical hallucinogen drug in rats: participation of 5-HT, dopamine and glutamate systems. Psychopharmacology (Berl). 2015;232:3797-808 pubmed publisher

Pail P, Costa K, Leite C, Campos M. Comparative pharmacological evaluation of the cathinone derivatives, mephedrone and methedrone, in mice. Neurotoxicology. 2015;50:71-80 pubmed publisher

Sheng Z, Cui X, Cui S, Yu B, Zhang X, Li S, et al. Involvement of adrenoceptors, dopamine receptors and AMPA receptors in antidepressant-like action of 7-O-ethylfangchinoline in mice. Acta Pharmacol Sin. 2015;36:949-56 pubmed publisher

Ciudad Roberts A, Camarasa J, Ciudad C, Pubill D, Escubedo E. Alcohol enhances the psychostimulant and conditioning effects of mephedrone in adolescent mice; postulation of unique roles of D3 receptors and BDNF in place preference acquisition. Br J Pharmacol. 2015;172:4970-84 pubmed publisher

Katare Y, Daya R, Sookram Gray C, Luckham R, Bhandari J, Chauhan A, et al. Brain Targeting of a Water Insoluble Antipsychotic Drug Haloperidol via the Intranasal Route Using PAMAM Dendrimer. Mol Pharm. 2015;12:3380-8 pubmed publisher

Rossmann J, Gurke R, Renner L, Oertel R, Kirch W. Evaluation of the matrix effect of different sample matrices for 33 pharmaceuticals by post-column infusion. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;1000:84-94 pubmed publisher

Oda Y, Tadokoro S, Takase M, Kanahara N, Watanabe H, Shirayama Y, et al. G protein-coupled receptor kinase 6/β-arrestin 2 system in a rat model of dopamine supersensitivity psychosis. J Psychopharmacol. 2015;29:1308-13 pubmed publisher

Angelini A, Ciofani G, Conti P. ANTIPSYCHOTICS REVERSE P-GLYCOPROTEIN-MEDIATED DOXORUBICIN RESISTANCE IN HUMAN UTERINE SARCOMA MES-SA/Dx5 CELLS: A NOVEL APPROACH TO CANCER CHEMOTHERAPY. J Biol Regul Homeost Agents. 2015;29:357-65 pubmed

Devroye C, Cathala A, Di Marco B, Caraci F, Drago F, Piazza P, et al. Central serotonin(2B) receptor blockade inhibits cocaine-induced hyperlocomotion independently of changes of subcortical dopamine outflow. Neuropharmacology. 2015;97:329-37 pubmed publisher

Stracina T, Slaninova I, Polanska H, Axmanova M, Olejnickova V, Konecny P, et al. Long-Term Haloperidol Treatment Prolongs QT Interval and Increases Expression of Sigma 1 and IP3 Receptors in Guinea Pig Hearts. Tohoku J Exp Med. 2015;236:199-207 pubmed publisher

Reuss B, Schroten H, Ishikawa H, Asif A. Cross-reactivity of Antibodies Directed to the Gram-Negative Bacterium Neisseria gonorrhoeae With Heat Shock Protein 60 and ATP-Binding Protein Correlates to Reduced Mitochondrial Activity in HIBCPP Choroid Plexus Papilloma Cells. J Mol Neurosci. 2015;57:123-38 pubmed publisher

Zielinski D, Filipp F, Bordbar A, Jensen K, Smith J, Herrgard M, et al. Pharmacogenomic and clinical data link non-pharmacokinetic metabolic dysregulation to drug side effect pathogenesis. Nat Commun. 2015;6:7101 pubmed publisher

de Souza I, Domingues D, Queiroz M. Hybrid silica monolith for microextraction by packed sorbent to determine drugs from plasma samples by liquid chromatography-tandem mass spectrometry. Talanta. 2015;140:166-175 pubmed publisher

Gentzel R, Toolan D, Roberts R, Koser A, Kandebo M, Hershey J, et al. The PDE10A inhibitor MP-10 and haloperidol produce distinct gene expression profiles in the striatum and influence cataleptic behavior in rodents. Neuropharmacology. 2015;99:256-63 pubmed publisher

Lušin T, Mrhar A, Trontelj J. UGT1A1*28 polymorphism influences glucuronidation of bazedoxifene. Pharmazie. 2015;70:94-6 pubmed

De Menil V, Knapp M, McDaid D, Raja S, Kingori J, Waruguru M, et al. Cost-effectiveness of the Mental Health and Development model for schizophrenia-spectrum and bipolar disorders in rural Kenya. Psychol Med. 2015;45:2747-56 pubmed publisher

Domingues D, Souza I, Queiroz M. Analysis of drugs in plasma samples from schizophrenic patients by column-switching liquid chromatography-tandem mass spectrometry with organic-inorganic hybrid cyanopropyl monolithic column. J Chromatogr B Analyt Technol Biomed Life Sci. 2015;993-994:26-35 pubmed publisher

Krieg B, Taghavi S, Amidon G, Amidon G. In Vivo Predictive Dissolution: Comparing the Effect of Bicarbonate and Phosphate Buffer on the Dissolution of Weak Acids and Weak Bases. J Pharm Sci. 2015;104:2894-904 pubmed publisher

Hasebe S, Ago Y, Nishiyama S, Oka S, Hashimoto H, Takuma K, et al. Pharmacological profile of encounter-induced hyperactivity in isolation-reared mice. Behav Pharmacol. 2015;26:681-90 pubmed publisher

Larrauri J, Burke D, Hall B, Levin E. Role of nicotinic receptors in the lateral habenula in the attenuation of amphetamine-induced prepulse inhibition deficits of the acoustic startle response in rats. Psychopharmacology (Berl). 2015;232:3009-17 pubmed publisher

McClay J, Vunck S, Batman A, Crowley J, Vann R, Beardsley P, et al. Neurochemical Metabolomics Reveals Disruption to Sphingolipid Metabolism Following Chronic Haloperidol Administration. J Neuroimmune Pharmacol. 2015;10:425-34 pubmed publisher

Li L, Chen Z, Bei W, Su Z, Huang Q, Zhang L, et al. Catecholamines promote Actinobacillus pleuropneumoniae growth by regulating iron metabolism. PLoS ONE. 2015;10:e0121887 pubmed publisher

Amato D, Pum M, Groos D, Lauber A, Huston J, Carey R, et al. Neuropharmacology of light-induced locomotor activation. Neuropharmacology. 2015;95:243-51 pubmed publisher

Edemann Callesen H, Voget M, Empl L, Vogel M, Wieske F, Rummel J, et al. Medial Forebrain Bundle Deep Brain Stimulation has Symptom-specific Anti-depressant Effects in Rats and as Opposed to Ventromedial Prefrontal Cortex Stimulation Interacts With the Reward System. Brain Stimul. 2015;8:714-23 pubmed publisher

Baba S, Murai T, Nakako T, Enomoto T, Ono M, Shimizu I, et al. The serotonin 5-HT₁A receptor agonist tandospirone improves executive function in common marmosets. Behav Brain Res. 2015;287:120-6 pubmed publisher

Hall B, Slade S, Allenby C, Kutlu M, Levin E. Neuro-anatomic mapping of dopamine D1 receptor involvement in nicotine self-administration in rats. Neuropharmacology. 2015;99:689-95 pubmed publisher

Chan H, Huang C, Feng W, Yen Y. Risperidone long-acting injection and 1-year rehospitalization rate of schizophrenia patients: A retrospective cohort study. Psychiatry Clin Neurosci. 2015;69:497-503 pubmed publisher

Hołuj M, Popik P, Nikiforuk A. Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors. Behav Pharmacol. 2015;26:766-75 pubmed publisher

Citraro R, Leo A, De Fazio P, De Sarro G, Russo E. Antidepressants but not antipsychotics have antiepileptogenic effects with limited effects on comorbid depressive-like behaviour in the WAG/Rij rat model of absence epilepsy. Br J Pharmacol. 2015;172:3177-88 pubmed publisher

Iderberg H, Maslava N, Thompson A, Bubser M, Niswender C, Hopkins C, et al. Pharmacological stimulation of metabotropic glutamate receptor type 4 in a rat model of Parkinson's disease and L-DOPA-induced dyskinesia: Comparison between a positive allosteric modulator and an orthosteric agonist. Neuropharmacology. 2015;95:121-9 pubmed publisher

Pantůčková P, Kubáň P, Boček P. Sensitivity enhancement in direct coupling of supported liquid membrane extractions to capillary electrophoresis by means of transient isotachophoresis and large electrokinetic injections. J Chromatogr A. 2015;1389:1-7 pubmed publisher

Cannella M, Motolese M, Bucci D, Molinaro G, Gradini R, Bruno V, et al. Changes in the expression of genes encoding for mGlu4 and mGlu5 receptors and other regulators of the indirect pathway in acute mouse models of drug-induced parkinsonism. Neuropharmacology. 2015;95:50-8 pubmed publisher

Shah A, Serajuddin A. Conversion of solid dispersion prepared by acid-base interaction into free-flowing and tabletable powder by using Neusilin® US2. Int J Pharm. 2015;484:172-80 pubmed publisher

Zheng M, Zhang H, Dill D, Clark J, Tu S, Yablonovitch A, et al. The role of Abcb5 alleles in susceptibility to haloperidol-induced toxicity in mice and humans. PLoS Med. 2015;12:e1001782 pubmed publisher

Fok M, Sepehry A, Frisch L, Sztramko R, Borger van der Burg B, Vochteloo A, et al. Do antipsychotics prevent postoperative delirium? A systematic review and meta-analysis. Int J Geriatr Psychiatry. 2015;30:333-44 pubmed publisher

Dwyer D, Awatramani P, Thakur R, Seeni R, Aamodt E. Social feeding in Caenorhabditis elegans is modulated by antipsychotic drugs and calmodulin and may serve as a protophenotype for asociality. Neuropharmacology. 2015;92:56-62 pubmed publisher

Deng C, Pan B, Hu C, Han M, Huang X. Differential effects of short- and long-term antipsychotic treatment on the expression of neuregulin-1 and ErbB4 receptors in the rat brain. Psychiatry Res. 2015;225:347-54 pubmed publisher

van der Sluis R, Nahon J, Reuwer A, Van Eck M, Hoekstra M. Haloperidol inhibits the development of atherosclerotic lesions in LDL receptor knockout mice. Br J Pharmacol. 2015;172:2397-405 pubmed publisher

Barlow R, Alsiö J, Jupp B, Rabinovich R, Shrestha S, Roberts A, et al. Markers of serotonergic function in the orbitofrontal cortex and dorsal raphé nucleus predict individual variation in spatial-discrimination serial reversal learning. Neuropsychopharmacology. 2015;40:1619-30 pubmed publisher

Pinder N, Zimmermann J, Hofer S, Brenner T, Weigand M, Gubbe U, et al. Revival of physostigmine - a novel HPLC assay for simultaneous determination of physostigmine and its metabolite eseroline designed for a pharmacokinetic study of septic patients. Clin Chem Lab Med. 2015;53:1259-64 pubmed publisher

Pulkoski Gross A, Li J, Zheng C, Li Y, Ouyang N, Rigas B, et al. Repurposing the antipsychotic trifluoperazine as an antimetastasis agent. Mol Pharmacol. 2015;87:501-12 pubmed publisher

Telegdy G, Adamik A. Neurotransmitter-mediated anxiogenic action of PACAP-38 in rats. Behav Brain Res. 2015;281:333-8 pubmed publisher

Suzuki K, Harada A, Shiraishi E, Kimura H. In vivo pharmacological characterization of TAK-063, a potent and selective phosphodiesterase 10A inhibitor with antipsychotic-like activity in rodents. J Pharmacol Exp Ther. 2015;352:471-9 pubmed publisher

Wang X, Kruglyak L. Genetic basis of haloperidol resistance in Saccharomyces cerevisiae is complex and dose dependent. PLoS Genet. 2014;10:e1004894 pubmed publisher

Mishra A, Mavlyutov T, Singh D, Biener G, Yang J, Oliver J, et al. The sigma-1 receptors are present in monomeric and oligomeric forms in living cells in the presence and absence of ligands. Biochem J. 2015;466:263-271 pubmed publisher

Alatorre A, Oviedo Chávez A, Villalobos N, Ríos A, Barrientos R, Querejeta E. The local application of a flavonoid, (-)-epicatechin, increases the spiking of globus pallidus neurons in a dose-dependent manner and diminishes the catalepsy induced by haloperidol. Behav Pharmacol. 2015;26:117-24 pubmed publisher

Gederaas O, Søgaard C, Viset T, Bachke S, Bruheim P, Arum C, et al. Increased Anticancer Efficacy of Intravesical Mitomycin C Therapy when Combined with a PCNA Targeting Peptide. Transl Oncol. 2014;7:812-23 pubmed publisher

Pasquarelli N, Porazik C, Hanselmann J, Weydt P, Ferger B, Witting A. Comparative biochemical characterization of the monoacylglycerol lipase inhibitor KML29 in brain, spinal cord, liver, spleen, fat and muscle tissue. Neuropharmacology. 2015;91:148-56 pubmed publisher

Qian Z, Xu Y, Zheng L, Zhang J, Hong Z, Shen X. Enantiospecific determination of arotinolol in rat plasma by LC-MS/MS: application to a stereoselective pharmacokinetic study. J Pharm Biomed Anal. 2015;102:299-304 pubmed publisher

Lilienthal H, Korkalainen M, Andersson P, Viluksela M. Developmental exposure to purity-controlled polychlorinated biphenyl congeners (PCB74 and PCB95) in rats: effects on brainstem auditory evoked potentials and catalepsy. Toxicology. 2015;327:22-31 pubmed publisher

Brust T, Hayes M, Roman D, Watts V. New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling. Biochem Pharmacol. 2015;93:85-91 pubmed publisher

Chen M, Wu S, Tsai T, Wang L, Tsai F. Regulation of neutrophil phagocytosis of Escherichia coli by antipsychotic drugs. Int Immunopharmacol. 2014;23:550-7 pubmed publisher

Oyamada Y, Horiguchi M, Rajagopal L, Miyauchi M, Meltzer H. Combined serotonin (5-HT)1A agonism, 5-HT(2A) and dopamine Dâ‚‚ receptor antagonism reproduces atypical antipsychotic drug effects on phencyclidine-impaired novel object recognition in rats. Behav Brain Res. 2015;285:165-75 pubmed publisher

Melo Thomas L, Thomas U. Deep brain stimulation of the inferior colliculus: a possible animal model to study paradoxical kinesia observed in some parkinsonian patients?. Behav Brain Res. 2015;279:1-8 pubmed publisher

Morris L, Nance K, Gentry P, Days E, Weaver C, Niswender C, et al. Discovery of (S)-2-cyclopentyl-N-((1-isopropylpyrrolidin2-yl)-9-methyl-1-oxo-2,9-dihydro-1H-pyrrido[3,4-b]indole-4-carboxamide (VU0453379): a novel, CNS penetrant glucagon-like peptide 1 receptor (GLP-1R) positive allosteric modulator (PAM). J Med Chem. 2014;57:10192-7 pubmed publisher

Citraro R, Leo A, Aiello R, Pugliese M, Russo E, De Sarro G. Comparative analysis of the treatment of chronic antipsychotic drugs on epileptic susceptibility in genetically epilepsy-prone rats. Neurotherapeutics. 2015;12:250-62 pubmed publisher

Rana D, Patel A, Joshi C, Jhala M, Goyal R. Alteration in the expression of exon IIC transcripts of brain-derived neurotrophic factor gene by simvastatin [correction of simvastain] in chronic mild stress in mice: a possible link with dopaminergic pathway. Can J Physiol Pharmacol. 2014;92:985-92 pubmed publisher

Gassen N, Hartmann J, Zschocke J, Stepan J, Häfner K, Zellner A, et al. Association of FKBP51 with priming of autophagy pathways and mediation of antidepressant treatment response: evidence in cells, mice, and humans. PLoS Med. 2014;11:e1001755 pubmed publisher

Baker T, Florczynski M, Beninger R. Differential effects of clozapine, metoclopramide, haloperidol and risperidone on acquisition and performance of operant responding in rats. Psychopharmacology (Berl). 2015;232:1535-43 pubmed publisher

Nguyen R, Morrissey M, Mahadevan V, Cajanding J, Woodin M, Yeomans J, et al. Parvalbumin and GAD65 interneuron inhibition in the ventral hippocampus induces distinct behavioral deficits relevant to schizophrenia. J Neurosci. 2014;34:14948-60 pubmed publisher

Arnhard K, Gottschall A, Pitterl F, Oberacher H. Applying 'Sequential Windowed Acquisition of All Theoretical Fragment Ion Mass Spectra' (SWATH) for systematic toxicological analysis with liquid chromatography-high-resolution tandem mass spectrometry. Anal Bioanal Chem. 2015;407:405-14 pubmed publisher

Versace F, Déglon J, Mangin P, Staub C. Application of direct-infusion ESI-MS/MS for toxicological screening. Bioanalysis. 2014;6:2043-55 pubmed publisher

Dekundy A, Mela F, Hofmann M, Danysz W. Effects of dopamine uptake inhibitor MRZ-9547 in animal models of Parkinson's disease. J Neural Transm (Vienna). 2015;122:809-18 pubmed publisher

Kawaura K, Koike H, Kinoshita K, Kambe D, Kaku A, Karasawa J, et al. Effects of a glycine transporter-1 inhibitor and D-serine on MK-801-induced immobility in the forced swimming test in rats. Behav Brain Res. 2015;278:186-92 pubmed publisher

Sredl D. Temptations after a medication error. J Christ Nurs. 2014;31:267 pubmed

Stroup T, McEvoy J, Hamer R. Antipsychotic medications for schizophrenia--reply. JAMA. 2014;312:1469 pubmed publisher

Suzuki T. Antipsychotic medications for schizophrenia. JAMA. 2014;312:1468-9 pubmed publisher

Fleischhacker W. Antipsychotic medications for schizophrenia. JAMA. 2014;312:1467-8 pubmed publisher

Min C, Zheng M, Zhang X, Guo S, Kwon K, Shin C, et al. N-linked Glycosylation on the N-terminus of the dopamine D2 and D3 receptors determines receptor association with specific microdomains in the plasma membrane. Biochim Biophys Acta. 2015;1853:41-51 pubmed publisher

Konopaske G, Lange N, Coyle J, Benes F. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014;71:1323-31 pubmed publisher

Sempio C, Morini L, Vignali C, Groppi A. Simple and sensitive screening and quantitative determination of 88 psychoactive drugs and their metabolites in blood through LC-MS/MS: application on postmortem samples. J Chromatogr B Analyt Technol Biomed Life Sci. 2014;970:1-7 pubmed publisher

Dos Santos Pereira J, Tadjerpisheh S, Abu Abed M, Saadatmand A, Weksler B, Romero I, et al. The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family. AAPS J. 2014;16:1247-58 pubmed publisher

Ferreira Júnior J, Conserva L, Lyra Lemos R, de Omena Neta G, Cavalcante Neto A, Barreto E. Isolation of a dihydrobenzofuran lignan, icariside E4, with an antinociceptive effect from Tabebuia roseo-alba (Ridley) Sandwith (Bignoniaceae) bark. Arch Pharm Res. 2015;38:950-6 pubmed publisher

Squillace M, Dodero L, Federici M, Migliarini S, Errico F, Napolitano F, et al. Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. Transl Psychiatry. 2014;4:e427 pubmed publisher

Patteet L, Maudens K, Stove C, Lambert W, Morrens M, Sabbe B, et al. The use of dried blood spots for quantification of 15 antipsychotics and 7 metabolites with ultra-high performance liquid chromatography - tandem mass spectrometry. Drug Test Anal. 2015;7:502-11 pubmed publisher

Anwar Mohamed A, Barakat K, Bhat R, Noskov S, Tyrrell D, Tuszynski J, et al. A human ether-á-go-go-related (hERG) ion channel atomistic model generated by long supercomputer molecular dynamics simulations and its use in predicting drug cardiotoxicity. Toxicol Lett. 2014;230:382-92 pubmed publisher

Pinkston J, Ginsburg B, Lamb R. Reinforcer magnitude and rate dependency: evaluation of resistance-to-change mechanisms. Behav Pharmacol. 2014;25:629-36 pubmed publisher

von Wilmsdorff M, Bouvier M, Henning U, Schmitt A, Schneider Axmann T, Gaebel W. Sex-dependent metabolic alterations of rat liver after 12-week exposition to haloperidol or clozapine. Horm Metab Res. 2014;46:782-8 pubmed publisher

Lever J, Miller D, Fergason Cantrell E, Green C, Watkinson L, Carmack T, et al. Relationship between cerebral sigma-1 receptor occupancy and attenuation of cocaine's motor stimulatory effects in mice by PD144418. J Pharmacol Exp Ther. 2014;351:153-63 pubmed publisher

Boomhower S, Rasmussen E. Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standard-chow diets. Behav Pharmacol. 2014;25:705-16 pubmed publisher

Fernández Suárez D, Celorrio M, Riezu Boj J, Ugarte A, Pacheco R, Gonzalez H, et al. Monoacylglycerol lipase inhibitor JZL184 is neuroprotective and alters glial cell phenotype in the chronic MPTP mouse model. Neurobiol Aging. 2014;35:2603-2616 pubmed publisher

Solntseva E, Kapai N, Popova O, Rogozin P, Skrebitsky V. The involvement of sigma1 receptors in donepezil-induced rescue of hippocampal LTP impaired by beta-amyloid peptide. Brain Res Bull. 2014;106:56-61 pubmed publisher

Sanna F, Piludu M, Corda M, Argiolas A, Giorgi O, Melis M. Dopamine is involved in the different patterns of copulatory behaviour of Roman high and low avoidance rats: studies with apomorphine and haloperidol. Pharmacol Biochem Behav. 2014;124:211-9 pubmed publisher

Mori T, Uzawa N, Kazawa H, Watanabe H, Mochizuki A, Shibasaki M, et al. Differential substitution for the discriminative stimulus effects of 3,4-methylenedioxymethamphetamine and methylphenidate in rats. J Pharmacol Exp Ther. 2014;350:403-11 pubmed publisher

Chen W, Zhu F, Guo J, Sheng J, Li W, Zhao X, et al. Chronic haloperidol increases voltage-gated Na+ currents in mouse cortical neurons. Biochem Biophys Res Commun. 2014;450:55-60 pubmed publisher

Gubellini P, Melon C, Dale E, Doller D, Kerkerian Le Goff L. Distinct effects of mGlu4 receptor positive allosteric modulators at corticostriatal vs. striatopallidal synapses may differentially contribute to their antiparkinsonian action. Neuropharmacology. 2014;85:166-77 pubmed publisher

Padakanti P, Zhang X, Jin H, Cui J, Wang R, Li J, et al. In vitro and in vivo characterization of two C-11-labeled pet tracers for vesicular acetylcholine transporter. Mol Imaging Biol. 2014;16:773-80 pubmed publisher

McEvoy J, Byerly M, Hamer R, Dominik R, Swartz M, Rosenheck R, et al. Effectiveness of paliperidone palmitate vs haloperidol decanoate for maintenance treatment of schizophrenia: a randomized clinical trial. JAMA. 2014;311:1978-87 pubmed publisher

Goff D. Maintenance treatment with long-acting injectable antipsychotics: comparing old with new. JAMA. 2014;311:1973-4 pubmed publisher

Winters S, Ghooray D, Yang R, Holmes J, O Brien A, Morgan J, et al. Dopamine-2 receptor activation suppresses PACAP expression in gonadotrophs. Endocrinology. 2014;155:2647-57 pubmed publisher

Waters S, Ponten H, Edling M, Svanberg B, Klamer D, Waters N. The dopaminergic stabilizers pridopidine and ordopidine enhance cortico-striatal Arc gene expression. J Neural Transm (Vienna). 2014;121:1337-47 pubmed publisher

Telegdy G, Foris L, Jászberényi M. Urocortin 3 administration impairs fear motivated learning in mice is mediated by transmitters. Behav Brain Res. 2014;270:326-9 pubmed publisher

Seip K, Jensen H, Kieu T, Gjelstad A, Pedersen Bjergaard S. Salt effects in electromembrane extraction. J Chromatogr A. 2014;1347:1-7 pubmed publisher

Lewitus G, Pribiag H, Duseja R, St Hilaire M, Stellwagen D. An adaptive role of TNF? in the regulation of striatal synapses. J Neurosci. 2014;34:6146-55 pubmed publisher

Maublanc J, Dulaurent S, Morichon J, Lachâtre G, Gaulier J. Identification and quantification of 35 psychotropic drugs and metabolites in hair by LC-MS/MS: application in forensic toxicology. Int J Legal Med. 2015;129:259-68 pubmed publisher

Oeckl P, Hengerer B, Ferger B. G-protein coupled receptor 6 deficiency alters striatal dopamine and cAMP concentrations and reduces dyskinesia in a mouse model of Parkinson's disease. Exp Neurol. 2014;257:1-9 pubmed publisher

Kulsoom H, Baig A, Siddiqui R, Khan N. Combined drug therapy in the management of granulomatous amoebic encephalitis due to Acanthamoeba spp., and Balamuthia mandrillaris. Exp Parasitol. 2014;145 Suppl:S115-20 pubmed publisher

Natesan S, Ashworth S, Nielsen J, Tang S, Salinas C, Kealey S, et al. Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [¹¹C]MP-10 PET rodent imaging study with ex vivo confirmation. Transl Psychiatry. 2014;4:e376 pubmed publisher

Medeiros P, Viana M, Barbosa Silva R, Tonelli L, Melo Thomas L. Glutamatergic neurotransmission in the inferior colliculus influences intrastriatal haloperidol-induced catalepsy. Behav Brain Res. 2014;268:8-13 pubmed publisher

Li J, Zhu S, Kozono D, Ng K, Futalan D, Shen Y, et al. Genome-wide shRNA screen revealed integrated mitogenic signaling between dopamine receptor D2 (DRD2) and epidermal growth factor receptor (EGFR) in glioblastoma. Oncotarget. 2014;5:882-93 pubmed

Riga M, Soria G, Tudela R, Artigas F, Celada P. The natural hallucinogen 5-MeO-DMT, component of Ayahuasca, disrupts cortical function in rats: reversal by antipsychotic drugs. Int J Neuropsychopharmacol. 2014;17:1269-82 pubmed publisher

Booij J, van Loon G, de Bruin K, Voorn P. Acute administration of haloperidol does not influence 123I-FP-CIT binding to the dopamine transporter. J Nucl Med. 2014;55:647-9 pubmed publisher

Redrobe J, Jørgensen M, Christoffersen C, Montezinho L, Bastlund J, Carnerup M, et al. In vitro and in vivo characterisation of Lu AF64280, a novel, brain penetrant phosphodiesterase (PDE) 2A inhibitor: potential relevance to cognitive deficits in schizophrenia. Psychopharmacology (Berl). 2014;231:3151-67 pubmed publisher

Li H, Wei C, Gao J, Bai S, Li H, Zhao Y, et al. Mediation of dopamine D2 receptors activation in post-conditioning-attenuated cardiomyocyte apoptosis. Exp Cell Res. 2014;323:118-30 pubmed publisher

Cazorla M, de Carvalho F, Chohan M, Shegda M, Chuhma N, Rayport S, et al. Dopamine D2 receptors regulate the anatomical and functional balance of basal ganglia circuitry. Neuron. 2014;81:153-64 pubmed publisher

Jeong J, Park Y, Kim D, Lee S, Kwak Y, Lee S, et al. Cdk5 phosphorylates dopamine D2 receptor and attenuates downstream signaling. PLoS ONE. 2013;8:e84482 pubmed publisher

Chandler A, Freeze Ramsey R, Seupaul R. Is the use of haloperidol a safe and effective method of tranquilization for patients with psychosis-induced aggression or agitation?. Ann Emerg Med. 2014;63:757-8 pubmed publisher

Adams C, Bergman H, Irving C, Lawrie S. Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev. 2013;:CD003082 pubmed publisher

Golden J, Demaro J, Knoten A, Hoshi M, Pehek E, Johnson E, et al. Dopamine-dependent compensation maintains motor behavior in mice with developmental ablation of dopaminergic neurons. J Neurosci. 2013;33:17095-107 pubmed publisher

Hughes D, Vanwert E, Lepori L, Adams B. Propofol for benzodiazepine-refractory alcohol withdrawal in a non-mechanically ventilated patient. Am J Emerg Med. 2014;32:112.e3-4 pubmed publisher

Hutchings E, Waller J, Terry A. Differential long-term effects of haloperidol and risperidone on the acquisition and performance of tasks of spatial working and short-term memory and sustained attention in rats. J Pharmacol Exp Ther. 2013;347:547-56 pubmed publisher

Donnelly L, Rathbone J, Adams C. Haloperidol dose for the acute phase of schizophrenia. Cochrane Database Syst Rev. 2013;:CD001951 pubmed publisher

Adán N, Guzmán Morales J, Ledesma Colunga M, Perales Canales S, Quintanar Stephano A, Lopez Barrera F, et al. Prolactin promotes cartilage survival and attenuates inflammation in inflammatory arthritis. J Clin Invest. 2013;123:3902-13 pubmed publisher

Oluwole L, Dada M, Obadeji A. Self-inflicted bilateral orchidectomy precipitated by erotic bizarre delusions: a case report. Afr J Psychiatry (Johannesbg). 2013;16:89, 91 pubmed

Uchida T, Suzuki T, Sakurai H, Tsutsumi C, Den R, Mimura M, et al. Ten year outcomes of outpatients with schizophrenia on conventional depot antipsychotics: a systematic chart review. Int Clin Psychopharmacol. 2013;28:261-6 pubmed publisher

Besusso D, Geibel M, Kramer D, Schneider T, Pendolino V, Picconi B, et al. BDNF-TrkB signaling in striatopallidal neurons controls inhibition of locomotor behavior. Nat Commun. 2013;4:2031 pubmed publisher

Mena A, De la Casa L. Prepulse inhibition modulation by contextual conditioning of dopaminergic activity. Behav Brain Res. 2013;252:188-94 pubmed publisher

Ebrahimzadeh H, Dehghani Z, Asgharinezhad A, Shekari N, Molaei K. Determination of haloperidol in biological samples using molecular imprinted polymer nanoparticles followed by HPLC-DAD detection. Int J Pharm. 2013;453:601-9 pubmed publisher

Telegdy G, Adamik A. Involvement of transmitters in the anxiolytic action of urocortin 3 in mice. Behav Brain Res. 2013;252:88-91 pubmed publisher

Vilibić M, Jukic V, Vidović A, Brecić P. Cobalamin deficiency manifested with seizures, mood oscillations, psychotic features and reversible dementia in the absence of typical neurologic and hematologic signs and symptoms: a case report. Coll Antropol. 2013;37:317-9 pubmed

Bonito Oliva A, Pallottino S, Bertran Gonzalez J, Girault J, Valjent E, Fisone G. Haloperidol promotes mTORC1-dependent phosphorylation of ribosomal protein S6 via dopamine- and cAMP-regulated phosphoprotein of 32 kDa and inhibition of protein phosphatase-1. Neuropharmacology. 2013;72:197-203 pubmed publisher

McLean S, Blenkinsopp A, Bennett M. Using haloperidol as an antiemetic in palliative care: informing practice through evidence from cancer treatment and postoperative contexts. J Pain Palliat Care Pharmacother. 2013;27:132-5 pubmed publisher

Ajiboye P, Yusuf A. Monosymptomatic Hypochondriacal Psychosis (somatic delusional disorder): a report of two cases. Afr J Psychiatry (Johannesbg). 2013;16:87, 89 pubmed publisher

Hickey J, Witsil J, Mycyk M. Haloperidol for treatment of cannabinoid hyperemesis syndrome. Am J Emerg Med. 2013;31:1003.e5-6 pubmed publisher

Emul M, Sakalli A, Erol T, Ertan T. Thyrotoxic psychosis in an elderly woman and haloperidol use: a case report. Psychogeriatrics. 2013;13:49-51 pubmed publisher

Kondo M, Tajinda K, Colantuoni C, Hiyama H, Seshadri S, Huang B, et al. Unique pharmacological actions of atypical neuroleptic quetiapine: possible role in cell cycle/fate control. Transl Psychiatry. 2013;3:e243 pubmed publisher

Kirk Morton N, Zubek D. Adherence challenges and long-acting injectable antipsychotic treatment in patients with schizophrenia. J Psychosoc Nurs Ment Health Serv. 2013;51:13-8 pubmed

Noain D, Pérez Millán M, Bello E, Luque G, Casas Cordero R, Gelman D, et al. Central dopamine D2 receptors regulate growth-hormone-dependent body growth and pheromone signaling to conspecific males. J Neurosci. 2013;33:5834-42 pubmed publisher

Dygai A, Skurikhin E, Ermakova N, Pershina O, Krupin V, Reztsova A, et al. Antifibrotic effect of combined treatment with neuroleptic drug and immobilized hyaluronidase in pulmonary fibrosis. Bull Exp Biol Med. 2013;154:329-33 pubmed

Tsuchie K, Miyaoka T, Furuya M, Liaury K, Ieda M, Wake R, et al. The effects of antipsychotics on behavioral abnormalities of the Gunn rat (unconjugated hyperbilirubinemia rat), a rat model of schizophrenia. Asian J Psychiatr. 2013;6:119-23 pubmed publisher

Kanburoglu M, Derinoz O, Cizmeci M, Havali C. Is acute dystonia an emergency? Sometimes, it really is!. Pediatr Emerg Care. 2013;29:380-2 pubmed publisher

Shireen E, Naeem S, Inam Q, Haleem D. Oral administration of haloperidol at clinically recommended doses elicits smaller parkinsonian effects but more tardive dyskinesia in rats. Pak J Pharm Sci. 2013;26:271-6 pubmed

Suzuki H, Gen K, Inoue Y. Comparison of the anti-dopamine D₂ and anti-serotonin 5-HT(2A) activities of chlorpromazine, bromperidol, haloperidol and second-generation antipsychotics parent compounds and metabolites thereof. J Psychopharmacol. 2013;27:396-400 pubmed publisher

Zhang H, Wang G, Zhao J, Xie S, Xu X, Shi J, et al. Intramuscular ziprasidone versus haloperidol for managing agitation in Chinese patients with schizophrenia. J Clin Psychopharmacol. 2013;33:178-85 pubmed publisher

Uys H. Prevalence and clinical presentation of HIV positive female psychiatric inpatients. Afr J Psychiatry (Johannesbg). 2013;16:23-8 pubmed publisher

Sundaramurthy V, Barsacchi R, Samusik N, Marsico G, Gilleron J, Kalaidzidis I, et al. Integration of chemical and RNAi multiparametric profiles identifies triggers of intracellular mycobacterial killing. Cell Host Microbe. 2013;13:129-42 pubmed publisher

Oganesian G, Aristakesian E, Romanova I, Vataev S, Kuzik V. [On filo- and ontogenetic development of dopaminergic regylation of wakefulness-sleep cycle in vertabrates]. Ross Fiziol Zh Im I M Sechenova. 2012;98:1213-27 pubmed

Shi L, Bian X, Qu Z, Ma Z, Zhou Y, Wang K, et al. Peptide hormone ghrelin enhances neuronal excitability by inhibition of Kv7/KCNQ channels. Nat Commun. 2013;4:1435 pubmed publisher

Crosby D, Peterson J, Carroll B. Atypical neuroleptic malignant syndrome in H1N1 pneumonia. Ann Clin Psychiatry. 2013;25:69-70 pubmed

Bell M, Sisk C. Dopamine mediates testosterone-induced social reward in male Syrian hamsters. Endocrinology. 2013;154:1225-34 pubmed publisher

Shan D, Lucas E, Drummond J, Haroutunian V, Meador Woodruff J, McCullumsmith R. Abnormal expression of glutamate transporters in temporal lobe areas in elderly patients with schizophrenia. Schizophr Res. 2013;144:1-8 pubmed publisher

Paine T, Asinof S, Diehl G, Frackman A, Leffler J. Medial prefrontal cortex lesions impair decision-making on a rodent gambling task: reversal by D1 receptor antagonist administration. Behav Brain Res. 2013;243:247-54 pubmed publisher

Metzl J. Mainstream anxieties about race in antipsychotic drug ads. Virtual Mentor. 2012;14:494-502 pubmed publisher

Kreiss D, Coffman C, Fiacco N, Granger J, Helton B, Jackson J, et al. Ritualistic chewing behavior induced by mCPP in the rat is an animal model of obsessive compulsive disorder. Pharmacol Biochem Behav. 2013;104:119-24 pubmed publisher

Jiang P, Zhang W, Li H, Cai H, Xue Y. Repeated haloperidol administration has no effect on vitamin D signaling but increase retinoid X receptors and Nur77 expression in rat prefrontal cortex. Cell Mol Neurobiol. 2013;33:309-12 pubmed publisher

Gonzalez D, Bienroth M, Curtis V, Debenham M, Jones S, Pitsi D, et al. Consensus statement on the use of intramuscular aripiprazole for the rapid control of agitation in bipolar mania and schizophrenia. Curr Med Res Opin. 2013;29:241-50 pubmed publisher

Madras B. History of the discovery of the antipsychotic dopamine D2 receptor: a basis for the dopamine hypothesis of schizophrenia. J Hist Neurosci. 2013;22:62-78 pubmed publisher

Mondelli V, Anacker C, Vernon A, Cattaneo A, Natesan S, Modo M, et al. Haloperidol and olanzapine mediate metabolic abnormalities through different molecular pathways. Transl Psychiatry. 2013;3:e208 pubmed publisher

Radomska K, Halvardson J, Reinius B, Lindholm Carlström E, Emilsson L, Feuk L, et al. RNA-binding protein QKI regulates Glial fibrillary acidic protein expression in human astrocytes. Hum Mol Genet. 2013;22:1373-82 pubmed publisher

Powney M, Adams C, Jones H. Haloperidol for psychosis-induced aggression or agitation (rapid tranquillisation). Cochrane Database Syst Rev. 2012;11:CD009377 pubmed publisher

Goikolea J, Colom F, Torres I, Capapey J, Valenti M, Undurraga J, et al. Lower rate of depressive switch following antimanic treatment with second-generation antipsychotics versus haloperidol. J Affect Disord. 2013;144:191-8 pubmed publisher

Diem O, Schäffner M, Seifarth W, Leib Mösch C. Influence of antipsychotic drugs on human endogenous retrovirus (HERV) transcription in brain cells. PLoS ONE. 2012;7:e30054 pubmed publisher

Wang E, Mabasa V, Loh G, Ensom M. Haloperidol dosing strategies in the treatment of delirium in the critically ill. Neurocrit Care. 2012;16:170-83 pubmed publisher

Klemp M, Tvete I, Skomedal T, Gaasemyr J, Natvig B, Aursnes I. A review and Bayesian meta-analysis of clinical efficacy and adverse effects of 4 atypical neuroleptic drugs compared with haloperidol and placebo. J Clin Psychopharmacol. 2011;31:698-704 pubmed publisher

Prommer E. Role of haloperidol in palliative medicine: an update. Am J Hosp Palliat Care. 2012;29:295-301 pubmed publisher

Schmalhofer W, Swensen A, Thomas B, Felix J, Haedo R, Solly K, et al. A pharmacologically validated, high-capacity, functional thallium flux assay for the human Ether-à-go-go related gene potassium channel. Assay Drug Dev Technol. 2010;8:714-26 pubmed publisher

Meyer Massetti C, Cheng C, Sharpe B, Meier C, Guglielmo B. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond?. J Hosp Med. 2010;5:E8-16 pubmed publisher

Huf G, Coutinho E, Adams C. [Haloperidol plus promethazine for agitated patients--a systematic review]. Braz J Psychiatr. 2009;31:265-70 pubmed

Pinder A, Pittaway E, Morris K, James P. Nitrite directly vasodilates hypoxic vasculature via nitric oxide-dependent and -independent pathways. Br J Pharmacol. 2009;157:1523-30 pubmed publisher

Huf G, Alexander J, Allen M, Raveendran N. Haloperidol plus promethazine for psychosis-induced aggression. Cochrane Database Syst Rev. 2009;:CD005146 pubmed publisher

Perkins P, Dorman S. Haloperidol for the treatment of nausea and vomiting in palliative care patients. Cochrane Database Syst Rev. 2009;:CD006271 pubmed publisher

Bellamy C, Kane Gill S, Falcione B, Seybert A. Neuroleptic malignant syndrome in traumatic brain injury patients treated with haloperidol. J Trauma. 2009;66:954-8 pubmed publisher

Schrader S, Wellik K, Demaerschalk B, Caselli R, Woodruff B, Wingerchuk D. Adjunctive haloperidol prophylaxis reduces postoperative delirium severity and duration in at-risk elderly patients. Neurologist. 2008;14:134-7 pubmed publisher

Leucht C, Kitzmantel M, Chua L, Kane J, Leucht S. Haloperidol versus chlorpromazine for schizophrenia. Cochrane Database Syst Rev. 2008;:CD004278 pubmed publisher

Perez Costas E, Guidetti P, Melendez Ferro M, Kelley J, Roberts R. Neuroleptics and animal models: feasibility of oral treatment monitored by plasma levels and receptor occupancy assays. J Neural Transm (Vienna). 2008;115:745-53 pubmed publisher

Awouters F, Lewi P. Forty years of antipsychotic Drug research--from haloperidol to paliperidone--with Dr. Paul Janssen. Arzneimittelforschung. 2007;57:625-32 pubmed

Rea R, Battistone S, Fong J, Devlin J. Atypical antipsychotics versus haloperidol for treatment of delirium in acutely ill patients. Pharmacotherapy. 2007;27:588-94 pubmed

Joy C, Adams C, Lawrie S. Haloperidol versus placebo for schizophrenia. Cochrane Database Syst Rev. 2006;:CD003082 pubmed

Cipriani A, Rendell J, Geddes J. Haloperidol alone or in combination for acute mania. Cochrane Database Syst Rev. 2006;:CD004362 pubmed

Hugenholtz G, Heerdink E, Stolker J, Meijer W, Egberts A, Nolen W. Haloperidol dose when used as active comparator in randomized controlled trials with atypical antipsychotics in schizophrenia: comparison with officially recommended doses. J Clin Psychiatry. 2006;67:897-903 pubmed

Nakahara T, Kuroki T, Hondo H, Tsutsumi T, Fukuda K, Yao H, et al. Effects of atypical antipsychotic drugs vs. haloperidol on expression of heat shock protein in the discrete brain regions of phencyclidine-treated rats. Brain Res Mol Brain Res. 1999;73:193-7 pubmed

Zhang W, Pouzet B, Jongen Rêlo A, Weiner I, Feldon J. Disruption of prepulse inhibition following N-methyl-D-aspartate infusion into the ventral hippocampus is antagonized by clozapine but not by haloperidol: a possible model for the screening of atypical antipsychotics. Neuroreport. 1999;10:2533-8 pubmed

Kim S, Kwon G, Shin S, Choe B. Expression of neuropeptide Y by glutamatergic stimulation in rat C6 glioma cells. Neurochem Int. 2000;36:19-26 pubmed